| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.004 |